HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Godden, S. Articles by Farnsworth, R. Search for Related Content PubMed PubMed Citation Articles by Godden, S. Articles by Farnsworth, R.

Effectiveness of an Internal Teat Seal in the Prevention of New Intramammary Infections During the Dry and Early-Lactation Periods in Dairy Cows when used with a Dry Cow Intramammary Antibiotic

S. Godden^*, P. Rapnicki^*, S. Stewart^*, J. Fetrow^*, A. Johnson, R. Bey and R. Farnsworth^*

^* Department of Clinical and Population Sciences, and
Department of Veterinary Diagnostic Medicine, Veterinary Teaching Hospital, University of Minnesota, St. Paul 55108
Total Herd Management Services, Clintonville, WI 54929

Corresponding author: S. Godden; e-mail: godde002{at}umn.edu.

The objectives of this study were to determine the effect of infusion with an internal teat seal at dry off, when used as an adjunct to long-acting antibiotic infusion at dry off, on the risk for acquiring a new intramammary infection (IMI) during the dry period, prevalence of IMI and linear score (LS) after calving, and risk for experiencing a clinical mastitis event between dry off and 60 DIM. A total of 437 cows from 2 dairy herds, with no clinical mastitis and 4 functional quarters, were enrolled at dry off. Prior to the final milking, all quarters were sampled for bacteriological culture and SCC analysis. After milking, all 4 quarters were infused with a commercially available long-acting dry cow antibiotic. Two contralateral quarters were then infused with an internal teat seal (Orbeseal, Pfizer Animal Health, New York). Following calving the teat seal was stripped out at first milking. Duplicate milk samples were collected between 1 to 3 DIM and again between 6 to 8 DIM for culture and SCC analysis. Quarters treated with Orbeseal had significantly lower prevalence of IMI at 1 to 3 DIM (tx = 22.8%, control = 29.1%), had significantly fewer quarters that acquired a new IMI between dry off and 1 to 3 DIM (tx = 20.2%, control = 25.4%), and had significantly fewer quarters affected by a clinical mastitis event between dry off and 60 DIM (tx = 5.9%, control = 8.0%). Multivariable analysis showed a significant effect of treatment, with treated quarters being 30% less likely to develop a new IMI between dry off and 1 to 3 DIM, 31% less likely to have an IMI present at 1 to 3 DIM, 33% less likely to experience a clinical mastitis event between dry off and 60 DIM, and having significantly lower linear score measures at 1 to 3 DIM and 6 to 8 DIM, compared with control quarters.

Key Words: internal teat seal • mastitis • dry period

Abbreviation key: CMT = California Mastitis Test, DCT = dry cow antibiotic therapy, LS = linear score, TMF = transition management facility

This article has been cited by other articles:

				T. Halasa, O. Osteras, H. Hogeveen, T. van Werven, and M. Nielen Meta-analysis of dry cow management for dairy cattle. Part 1. Protection against new intramammary infections J Dairy Sci, July 1, 2009; 92(7): 3134 - 3149. [Abstract] [Full Text] [PDF]

				J. C. F. Pantoja, C. Hulland, and P. L. Ruegg Somatic cell count status across the dry period as a risk factor for the development of clinical mastitis in the subsequent lactation J Dairy Sci, January 1, 2009; 92(1): 139 - 148. [Abstract] [Full Text] [PDF]

				H. T. Newton, M. J. Green, H. Benchaoui, V. Cracknell, T. Rowan, and A. J. Bradley Comparison of the efficacy of cloxacillin alone and cloxacillin combined with an internal teat sealant for dry-cow therapy Vet Rec., May 24, 2008; 162(21): 678 - 683. [Abstract] [Full Text] [PDF]

				K. I. Parker, C. W. R. Compton, F. M. Anniss, C. Heuer, and S. McDougall Quarter-Level Analysis of Subclinical and Clinical Mastitis in Primiparous Heifers Following the Use of a Teat Sealant or an Injectable Antibiotic, or Both, Precalving J Dairy Sci, January 1, 2008; 91(1): 169 - 181. [Abstract] [Full Text] [PDF]

				K. Huijps and H. Hogeveen Stochastic Modeling to Determine the Economic Effects of Blanket, Selective, and No Dry Cow Therapy J Dairy Sci, March 1, 2007; 90(3): 1225 - 1234. [Abstract] [Full Text] [PDF]

				G. H. Lim, K. E. Leslie, D. F. Kelton, T. F. Duffield, L. L. Timms, and R. T. Dingwell Adherence and Efficacy of an External Teat Sealant to Prevent New Intramammary Infections in the Dry Period J Dairy Sci, March 1, 2007; 90(3): 1289 - 1300. [Abstract] [Full Text] [PDF]

				G. H. Lim, D. F. Kelton, K. E. Leslie, L. L. Timms, C. Church, and R. T. Dingwell Herd Management Factors That Affect Duration and Variation of Adherence of an External Teat Sealant J Dairy Sci, March 1, 2007; 90(3): 1301 - 1309. [Abstract] [Full Text] [PDF]

				E. A. Berry and J. E. Hillerton Effect of an Intramammary Teat Seal and Dry Cow Antibiotic in Relation to Dry Period Length on Postpartum Mastitis J Dairy Sci, February 1, 2007; 90(2): 760 - 765. [Abstract] [Full Text] [PDF]